abstract |
The present invention provides bispecific polypeptides comprising a first binding domain designated B1 capable of targeting dendritic cells and a second binding domain designated B2 capable of targeting a tumor cell associated antigen. Pharmaceutical compositions of such bispecific polypeptides and their use in medicine are also provided. |